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ABSTRACT 
The Effects of Prevention and Public Health Expenditure on Measles Immunization 
Rates in Organisation for Economic Co-operation and Development (OECD) Countries. 
(August 2007) 
Christina Melonie Chen, B.A., Rice University 
Chair of Advisory Committee: Dr. James Eddy 
  
 
 
Globalization has brought health concerns to the forefront. Moreover, 
governments, policymakers, and health officials are paying more attention to these 
health concerns. With the increased cross-national interaction, diseases have more 
pathways to spread than ever. As countries attempt to ensure access to care and control 
health expenditure, monitoring and improving the quality of health care is a pressing 
issue. This paper uses linear regressions to analyze the relationship between prevention 
and public health expenditure and the rate of measles immunizations in member 
countries of the Organisation of Economic Co-operation and Development (OECD).  
There is a weak negative relationship between the expenditure and rates of 
measles immunizations for both private and public expenditure data, suggesting that the 
higher the expenditure the lower the rates of measles immunizations. Several possible 
reasons for this phenomenon is discussed in conjunction with the role of health educators 
as it relates to the use of theory based interventions to improve rates of measles 
immunizations.  
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CHAPTER I 
 
INTRODUCTION: MEASLES AS A GLOBAL HEALTH THREAT 
 
Globalization has brought about the interconnectedness of diverse countries 
through economic, social and political forces (Doyal, 2002). Unrestricted population 
movement is likely as millions migrate for multiple reasons (Daulaire, 2003). There is a 
growing understanding that health now transcends national borders, and as the world 
becomes better connected, the nature of diseases will also become more globalized 
(Daulaire; Taylor, 2004). As diseases do not respect national boundaries, the increase of 
cross-national interaction implies that infectious diseases are no longer a concern solely 
for the developing countries (Waters, 2001). According to Taylor, the number and scale 
of transboundary public health concerns, including infections diseases, are indeed 
increasing. 
The spread of AIDS and reappearance of tuberculosis in many developed 
countries have taught policymakers and governments the importance of remaining 
vigilant in public health and health promotion efforts to control and prevent infections 
diseases (Waters, 2001). More recently, the concern for measles has been gaining 
attention because as one of the most contagious human diseases, the threat of using 
measles as a bioterrorist weapon exists (Strebel et al., 2003; Meissner, Strebel, & 
Orenstein, 2004).  
 
 
This thesis follows the style of The Health Educator. 
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In addition, importation, cases classified as persons infected with the measles 
virus while outside their home country during the 21 days before rash onset, has become 
more common in the past two decades. It now is responsible for nearly half of all 
reported measles cases in the United States (Centers for Disease Control and Prevention 
[CDC], 1999; Oster, Harpaz, Redd, & Papania, 2004). Worldwide, measles is a heavy 
public health burden, with 30-40 million cases and 745,000 deaths in 2001 representing 
50%-60% of all vaccine preventable deaths in children worldwide (World Health 
Organization [WHO], 2002). While developed countries are not endemic to measles, 
importation and circulation of measles will continue as long as measles is prevalent in 
developing countries (Meissner et al., 2004; CDC, 2004).  
Efforts to combat measles are common. For example, the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease Registry lists 
both “vaccine preventable diseases,” and “improved immunization coverage and 
introduction of new childhood vaccines in many countries” as priority programs in their 
Global Health Strategy (Walker, Evans, & Mouton, 2006); the United Nations Special 
Session on Children endorsed the goal of reducing measles death (Strebel et al., 2003); 
and the World Health Organization adopted aggressive measles control or elimination 
strategies (Strebel et al.). These efforts emphasize the global nature of the disease and 
the need for cross-national joint efforts.  
With the increase of transnational agenda setting in efforts to target measles, 
global tracking of measles immunization rates and analyses are important for 
comparison of health status. In addition, governments can learn from one another in the 
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prevention and containment of diseases and make sense of the challenges in their own 
countries (Murphy, 2007). 
The Organisation for Economic Co-operation and Development (OECD) is one 
organization that has realized and acted on the need for cross-national data collection 
and management. The OECD (2007) is a group of 30 like-minded countries, and 
represents the world’s most developed and wealthy nations, producing about 60% of the 
world’s goods and services. As such, high levels of trade and cross-national business are 
characteristics of member countries, increasing the necessity for health status 
monitoring.  
As a basic health status indicator, the measles immunization agenda has been 
termed unfinished (Strebel et al., 2003) and factors associated with improved measles 
immunization rates in developed countries have not been determined. This paper poses a 
basic research question: Is expenditure towards prevention and public health in OECD 
countries related to measles immunization rates? Using OECD Health Data 2006, this 
paper analyzes the relationship between prevention and public health expenditure on 
measles immunization rates OECD countries.  
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CHAPTER II 
ARTICLE: THE EFFECTS OF PREVENTION AND  
PUBLIC HEALTH SPENDING ON MEASLES  
IMMUNIZATION RATES IN ORGANISATION FOR ECONOMIC 
CO-OPERATION AND DEVELOPMENT (OECD) COUNTRIES 
 
Introduction 
 
Due to globalization, population health is now a cross-national interest for 
multiple parties. Despite the difference in funding and delivery of health care, common 
challenges across nations exist (Murphy, 2007; Haux, Ammenwerth, Herzog, & Knaup, 
2003; Hall & Walton, 2004). Economists, policy analysts, and health officials are all 
working towards understanding international health (Doyal, 2002; Cornia, 2001; Dollar, 
2001; Drager & Beaglehole, 2001; Feachem, 2001; Weisbrot et al., 2001). Because of 
the significant potential to learn from countries that may be ahead in planning and 
development of health care, shared information and research across nations is crucial 
(Murphy).  
Particularly, cross-national tracking of health expenditure have been scrutinized 
by policy analysts, economists, and researchers. Since the 1980s, researchers have been 
able to track diminishing returns in life expectancy gains from increased health 
expenditures (Newhouse, 1987). This raises the important question of what is being 
purchased with the increase in health finances (Berman, 1997).  
 5
The Organisation for Economic Co-operation and Development (OECD) has 
gathered and published information on the availability on various health measures, 
including health expenditure and health status measures. Specifically, because there has 
been limited research in the area of prevention and public health expenditure, and as a 
basic health status indicator, the measles immunization agenda has been termed 
unfinished (Strebel et al., 2003), this paper poses a basic research question: Is 
expenditure towards prevention and public health in OECD countries related to measles 
immunization rates? This relationship is examined using OECD Health Data 2006. 
Additionally implications for the Health Education profession are made.  
Method 
Data Source 
Data from the OECD Health Data 2006 were analyzed. OECD Health Data 2006 
is an electronic database, containing aggregate data on the health care systems of the 30 
OECD countries from 1960 to 2005. Data are collected and reported by the member 
countries directly to the OECD for publication. All OECD Health 2006 data are 
available at www.sourceoecd.org to subscribers.  
This study included two measures in the data set: 1) Prevention and Public 
Health Expenditure per capita, using purchasing power parity (PPP) rates to convert 
from national currency to U.S. dollars (Table 1); and 2) Rates of measles immunization 
by the age of one in percentages (Table 2). PPP rates, which relate the prices of a market 
basket of goods in one country to the comparative group of countries, have been 
accepted for use when analyzing health expenditures and health outcomes (Schieber & 
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Poullier, 1991). Data were a taken from select years between 1999-2005 using the most 
recent reported measles immunization percentage and prevention and public health 
expenditure for the given countries.  
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Table 1 
Prevention and Public Health Expenditure (USDPPP) 
Country Total Public Private 
Australia 46 44 2 
Austria 63 42 21 
Belgium* 40 40 0 
Canada 185 184 1 
Czech Republic 27 23 4 
Denmark 15 13 2 
Finland 87 41 47 
France 90 68 22 
Germany 100 86 15 
Greece 65 35 30 
Hungary** 54 29 24 
Iceland 40 40 0 
Ireland 78 59 19 
Italy 15 15 0 
Japan* 50 30 20 
Korea 21 20 1 
Luxembourg 63 61 2 
Mexico 18 18 0 
Netherlands 148 76 71 
New Zealand 62 48 14 
Norway 75 65 11 
Poland 14 12 2 
Portugal 36 24 12 
Slovak Republic* 13 13 0 
Spain 29 21 8 
Sweden 85 76 9 
Switzerland 89 57 32 
Turkey*** 10 10 0 
United Kingdom**** 30 30 0 
United States 224 206 18 
All data from 2004, unless otherwise noted. 
* Data from 2003 
** Data from 2002 
*** Data from 2000 
****Data from 1999 
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Table 2 
Percent Children Immunized Against Measles 
Country % Children Immunized 
Australia* 93.4 
Austria 74.0 
Belgium 82.0 
Canada** 94.5 
Czech Republic 96.9 
Denmark 96.0 
Finland 97.0 
France 87.1 
Germany 93.3 
Greece 88.0 
Hungary 99.9 
Iceland* 99.0 
Ireland 81.0 
Italy 85.5 
Japan*** 100.0 
Korea**** 90.2 
Luxembourg 91.0 
Mexico 96.4 
Netherlands 96.0 
New Zealand 85.0 
Norway 88.0 
Poland 97.0 
Portugal 94.8 
Slovak Republic 99.6 
Spain 97.3 
Sweden 94.0 
Switzerland 82.0 
Turkey* 90.0 
United Kingdom* 81.7 
United States 93.0 
All data from 2004 unless otherwise noted.  
* Data from 2005 
** Data from 2002 
***Data from 2000 
****Data from 1999 
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Definitions 
OECD Measures of Expenditure on Prevention and Public Health 
The OECD defines expenditure on prevention and public health to include 
“services designed to enhance the health status of the population as distinct from the 
curative services which repair health dysfunction (OECD, 2007).” Typical services in 
the classification include vaccination campaigns and programs (OECD, 2007). Data are 
taken from 1999-2004, using the most recent reported expenditure. Data on prevention 
and public health expenditure are categorized into three sets: 1) total expenditure, 2) 
public expenditure, and 3) private expenditure (Table 1). Public expenditure accounts for 
government funded projects and private expenditure accounts for occupational health 
care, charities, non-governmental organizations, and voluntary organizations funded 
projects.  
OECD Measures of Immunization 
OECD defines measles immunization rates as “the percentage of children 
reaching their first birthday who have been fully immunized against measles” (OECD, 
2007). Data are used from years 1999-2005, taking the most recent data for the 
countries. Table 2 indicates which years data were drawn from for each country.  
Missing Data 
As reported by OECD (2005), OECD countries on average spend 3% of total 
health care expenditure on prevention and public health. Data on Prevention and public 
health expenditure was unavailable for four countries, Greece, Ireland, New Zealand, 
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and Sweden. For these countries, figures were estimated using 3% of total health care 
expenditure (also reported in OECD Health Data 2006).  
Statistical Procedures 
Secondary data analysis was carried out using Statistical Package for the Social 
Sciences version 14.0 (SPSS). Descriptive statistics were obtained and linear regression 
models were estimated. Pearson’s correlations are reported as well as the p-value of 
findings. The models are estimated with prevention and public health expenditure as the 
independent variable and measles immunization rates as the dependent variable. The 
equations are estimated with the following general form of Yi=ßXi+Ui where X 
represents the prevention and public health expenditure and i = 1, 2, …, 30 OECD 
countries. The error is assumed to be independent and identical across the i countries. 
Due to lack of previous research related to this study, only the effect of prevention and 
public health expenditure is considered. Confounding variables are not considered, 
however will be addressed in the discussion.  
Data were analyzed in three sets: 1) total prevention and public health 
expenditure on measles immunization rates; 2) public funding of prevention and public 
health expenditure on measles immunization rates; and 3) private funding of prevention 
and public health expenditure on measles immunization rates.  
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Table 3 
Statistical Results 
Dependent 
Variable 
Independent Variable – 
Expenditure on 
Prevention and Public 
Health 
Coefficient Constant p-value R
2
 
Total  -0.0046 91.742 .856 .001 
Public -0.0056 91.729 .001 .846 
Measles 
Immunization 
Rate Private -0.003 91.497 .846 .0008 
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Results 
Descriptive Statistics 
Prevention and Public Health Expenditure 
Total expenditure ranged from 10 million to 224 million, Turkey and the United 
States, respectively. The mean total expenditure was 64.4 million with standard 
deviation of 50.58. Public expenditure towards prevention and public health ranged from 
10 million to 206 million, Turkey and the United States, respectively. The mean public 
expenditure was 49.96 million with standard deviation of 44.88. Private expenditure 
towards prevention and public health ranged from 0 million to 71 million. Belgium, 
Iceland, Italy, Mexico, Slovak Republic, Turkey, and United Kingdom were at 0 million 
for private expenditure, and the Netherlands at 71 million. The mean private expenditure 
was 12.93 million with standard deviation of 16.25.  
For few countries, 100% of all prevention and public health expenditure is 
funded through public sources; however for the majority of OECD countries, total 
expenditure is a combination of both public and private funds. For Finland, Hungary, 
Germany, Netherlands, and Norway, there was a discrepancy in the data of 1 million 
dollars when public and private expenditure were added and compared to the total 
expenditure. This is possibly attributed to rounding and approximation in the data. A 
second source of data was unable to be located, and the data were analyzed using the 
reported values.  
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Measles Immunization 
Percent of children immunized ranged from 74% to 100%, Austria and Japan, 
respectively. The mean immunization rate is 91.5% with standard deviation of 6.7. Data 
were available for all countries.  
Regression and Correlation 
Total Prevention and Public Health Expenditure  
There is no significant relationship between total prevention and public health 
expenditure and measles immunization rates (Figure 1). However, the direction of effect 
indicates that the higher the expenditure on prevention and public health, the lower the 
rates of measles immunization. Pearson correlation = -.035, with a linear regression 
equation of y = -0.0046x + 91.742 and R2 = 0.001 (p = .856) (Table 3). The three 
outliers belong to the United States, Canada, and the Netherlands. After accounting for 
the outliers, R2 = .083 and Pearson’s correlation = -.289 (p = .144), making the 
relationship stronger, but still not significant at p < .10.  
Public Expenditure on Prevention and Public Health  
Public funding on prevention and public health expenditure has no significant 
relationship with measles immunization rates (Figure 2). Pearson’s correlation = -.037, 
with a linear regression equation y = -0.0056x + 91.729 and R2 = .001 (p = .846). The 
two outliers belong to Canada and the United States. After accounting for the outliers, R2 
= .061 and Pearson’s correlation = -.248 (p = .203), making the relationship stronger, but 
still not significant at p < .10.  
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Figure 1 
Total Prevention and Public Health Expenditure on Measles Immunization Rates 
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Figure 2 
Public Expenditure on Prevention and Public Health on Measles Immunization Rates 
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Figure 3 
Private Expenditure on Prevention and Public Health on Measles Immunization Rates 
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Private Expenditure on Prevention and Public Health 
Private funding on prevention and public health expenditure has no significant 
relationship with measles immunization rates (Figure 3). Pearson’s correlation = -.008, 
with a linear regression equation y = -0.003x + 91.497 and R2 = .008 (p = .846). The two 
outliers belong to Finland and the Netherlands. After accounting for the outliers, R2 = 
.075 and Pearson’s correlation = -.274 (p = .158), making the relationship stronger, but 
still not significant at p < .10.  
Discussion 
This study contributes to the limited body of knowledge on prevention and public 
health expenditure as it relates to measles immunization rates. Particularly, this study is 
unique because it analyzes data from member countries of the OECD, the most 
developed nations in the world. The results demonstrated that for OECD countries, 
prevention and public health expenditure (total, public, and private) are not strongly 
related to measles immunization rates. This finding is significant because although the 
OECD mentions immunization campaigns as part of prevention and public health 
expenditure, there was no correlation with measles immunization. This raises several 
research questions including which immunization campaigns receive the funds and how 
effective are immunization campaigns. In addition, since expenditure towards 
immunization is only a fraction of the total prevention and public health expenditure, 
this leads to research of prevention and public health expenditures and the methods of 
data tracking. 
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Limitations  
Because this paper only used data from the OECD, the findings may not be 
generalizable to countries outside the OECD. While the OECD represents of the most 
developed countries of the world, membership in the organization may provide for 
external pressure faced by these countries. The OECD also claims that they are a group 
of “like-minded countries,” reemphasizing the inability to generalize these findings.  
The assumptions associated with this secondary data set are that the data captures 
similar measurements between the countries. However, when comparing cross-national 
data, three limitations often apply. First the data are collected for operational rather than 
research purposes and therefore may carry with them country-specific definitions 
(Reinhardt, 2002). Second, the boundary between health and social services is often 
unclear and the reported figures may not capture all the related spending (Schieber & 
Poullier, 1991). Third, there is a lack of internationally accepted definitions of many 
health related terms and unintended confusion even with the operational definitions 
(Schieber & Poullier), and therefore national reporting of prevention and public health 
expenditure could potentially capture different measures. These assumptions and 
limitations among the data set cannot be addressed until further research is initiated in 
these countries and more comparable data is collected.  
However, it should also be emphasized that these data measurement problems 
have not deterred health policy analyst, researchers, or the popular press from drawing 
substantive conclusions of the performance (Grubaugh & Santerre, 1994). In addition, it 
is advantageous that these data are based on an internationally accepted functional 
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classification and are monitored by statistical offices of the countries (Schieber & 
Poullier, 1991). 
Implications 
 Several explanations pertaining to the weak correlation between increased public 
and prevention health expenditure and measles immunization rates are discussed below. 
Future studies are also suggested which may help explain this phenomenon.  
Fewer Measles Cases 
According to the Health Belief Model, people fail to take action if they have a 
low perceived risk of contracting the disease, or they perceive the risks associated with 
the disease as low. As higher prevention and public health expenditure may result in 
lower measles prevalence, people may not be aware of the disease or believe themselves 
to be less susceptible to the disease and forgo proper immunization. However, even in 
countries were measles are not endemic, children not immunized may experience more 
than a 60-fold increase in risk of disease due to importation (Meissner et al., 2004). 
Future research should explore if countries with higher expenditure on prevention and 
public health have fewer cases of measles, and if such is the case, develop methods to 
raise awareness among individuals of the need for proper immunization. 
Funding of Campaigns Unrelated to Measles 
There is currently no tracking system to identify and record the allocation of 
prevention and public health expenditure. Without a tracking system, it is difficult to 
analyze the overall effects of prevention and public health expenditure in a nation 
because of the numerous programs which receive funding. The lack of information can 
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be addressed by governmental and health agencies by recording the allocation of 
prevention and public health expenditures. With this information, governments, policy-
makers and health educators can better analyze the relationship between prevention and 
public health expenditure and health status, including measles immunization rates.  
Governance 
Taylor (2004) concluded that globalization is creating a heightened need for new 
global health governance structures to promote coordinated intergovernmental action. 
However, few studies have attempted to determine the relationship between governance 
and health status. A relatively new line of research has given attention to broader 
measures of health, such as mortality (Novarro et al., 2003), yet immunization rates may 
not share the same characteristics as broad measures such as mortality. Immunizations 
are often state mandated; therefore the form of governance and health care structure may 
play an important role.   
The Private Sector 
The private sector currently is not a large contributor towards prevention and 
public health (ranging from only $0 - $71 USPPP per capita, compared to $10 – $206 
USPPP per capita contributed by the public sector). However, it has been the case 
through history that the private sector was first to capitalize on the current wave of 
globalization (Daulaire, 2003). In addition, forward-thinking entities in the private sector 
have already begun to realize the health threats associated with transnational movement 
and are beginning to use global health promotion to ensure optimal market access 
(Daulaire). These agencies should capitalize on the fact that they are not bound by 
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geography, and can simultaneously work in multiple nations. Transnational health 
organizations also can help mobilize public opinion in these countries, guiding 
diplomatic institutions (Daulaire). These private organizations also may have more 
freedom in the expenditure of funds, and can have more freedom in designing and 
delivering public health programs. Future studies should attempt to capture how these 
entities can be involved in measles immunization campaigns. 
Health Education in Practice 
Health educators need to adopt an international scope towards heath education 
and promotion. As globalization increases the global health influence, health educators 
will be forced into taking on additional responsibilities.  
The measles immunization agenda is unfinished and discerning factors 
contributing to increased immunization is important. In addition, the potential for 
substantial cost savings makes reduction in disease prevalence valuable and 
policymakers at all levels will benefit to recognize the impact of increased prevention 
and public health expenditure (Carabin & Edmunds, 2003).  
Furthermore, as health educators, it is important to realize that increased health 
expenditure may not always correlate to improved health status measures. With training 
in the conducting needs assessment, developing, implementing, and evaluating 
programs, health educators must play a crucial role in improving the efficacy and 
efficiency in the measles immunization agenda.  
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CHAPTER III 
CONCLUSION 
 
Globalization has brought health issues to the forefront grabbing policy makers, 
health officials and government organizations’ attention. As diseases are not bound by 
national borders, the frequent cross-national contact through people and product flows 
continues to heighten the need for a cross-national research and interventions in health 
issues. 
Immunizations against preventable diseases are particularly important 
worldwide. Moreover, nations that have access to and can afford the immunizations need 
to ensure that the national population is receiving the proper dosages of protection. 
Measles is one of the top five killers of children under five (Strebel et al., 2003), and the 
WHO has initiated a call for the eradication of this disease. Therefore, this paper 
specifically examines the relationship between measles immunization rates and 
prevention and public health expenditure. 
The countries included in this study are all members of the Organisation for 
Economic Co-operation and Development (OECD), which represent the most developed 
nations worldwide. Decision to use this set of countries was based on the assumption 
that available funding and provision are available to provide the population with measles 
immunizations, and development, economic and living standards are comparable 
between the countries.  
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Data for this paper were collected from the OECD Health Status 2006 report. 
This information is public domain and can be accessed from www.sourceoecd.org. 
Much research has been conducted with OECD data; however, this paper fills the void in 
the analyses of prevention and public health expenditure, which accounts for an OECD 
average of 3% of total health expenditure (OECD, 2005)  
Analyses were conducted in order to determine the relationship between 
prevention and public health expenditure and measles immunization rates. Data were a 
compilation of the most recent statistics provided for countries, ranging from year 1990-
2005. Missing data were estimated based on findings from the literature. 
Regression models were estimated for: 1) total prevention and public health 
expenditure on measles immunization rates; 2) public expenditure towards prevention 
and public health on measles immunization rates; and 3) private expenditure towards 
prevention and public health on measles immunization rates.  
The relationship between prevention and public health expenditure and measles 
immunization rates are not statistically significant in OECD countries. Results strongly 
suggest that prevention and public health expenditure is not related to measles 
immunization rates in the OECD countries. However, there is a slight negative 
correlation, hinting that higher expenditure on prevention and public health, results in a 
lower percentage of children under the age of one immunized against measles.  
Studies have not been conducted to determine factors that influence measles 
immunization rates in developed countries and this paper opens discussion in this area 
laying the groundwork for future studies. Findings here suggest that a broader 
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consideration beyond monetary spending may have to be considered to fully understand 
the relationship between expenditure and health. Suggestions presented included the 
need for more data tracking, isolating for various factors of expenditure, and determining 
if there is a relationship between governance and immunization rates.  
Lastly, this study indicated how health educators can contribute to raising 
measles immunization rates in developed countries.  Health educators must be 
responsible for conducting research projects related to measles immunizations. With the 
skills set to conduct needs assessments, develop, implement and evaluate programs, 
health educators are responsible for researching reasons why individuals do not receive 
the immunization. Furthermore, health educators need to determine which population 
subset is at risk for not receiving the immunization and develop targeted interventions to 
increase immunization rates among these subpopulations. Aiding in the increase of 
measles immunization rates is particularly important to promote global health, and 
health educators must take responsibility in this area.  
 25
REFERENCES 
Berman, P. (1997). National health accounts in developing countries: Appropriate 
methods and recent applications. Health Economics, 6, 11-30.  
 
Carabin, H. & Edmunds, J. (2003). Future savings from measles eradication in 
industrialized countries. Journal of Infectious Diseases, 187(Suppl. 1), 29-35.  
 
Centers for Disease Control and Prevention. (1999). Manual for the surveillance of 
vaccine-preventable diseases. Atlanta, GA: Author.  
 
Centers for Disease Control and Prevention. (2004). Imported measles case associated 
with nonmedical vaccine exemption – Iowa, March 2004. Morbidity and Mortality 
Weekly Report, 2004(53), 244-246.  
 
Cornia, G. (2001). Globalisation and health: Results and options. Bulletin of the World 
Health Organization, 79(9), 834-841. 
 
Dollar, D. (2001). Is globalization good for your health? Bulletin of the World Health 
Organisation, 79(9), 827-833.  
 
Doyal, L. (2002). Putting gender into health and globalization debates: New perspectives 
and old challenges. Third World Quarterly 23(2), 233-250.  
 
Drager, N. & Beaglehole, R. (2001). Globalization: Changing the public health 
landscape. Bulletin of the World Health Organization, 79(9), 803.  
 
Daulaire, N. (2003). Beyond trade: Taking globalization to the health sector. New 
Solutions, 13(1), 67-71.  
 
Feachem, R. (2001). Globalisation is good for your health, mostly. British Medical 
Journal, 323, 504-506. 
 
Grubaugh, S. & Santerre, R. (1994). Comparing the performance of health care systems: 
An alternative approach. Southern Economic Journal, 60(4), 1030-1042.  
 
Hall, A. & Graham Walton, G. (2004) Information overload within the health care 
system: A literature review. Health Information and Libraries Journal, 21, 102-108. 
 
Haux, R., Ammenwerth, E., Herzog, W., & Knaup, P. (2003) Health care in the 
information society. A prognosis for the year 2013. International Journal of Medical 
Informatics, 66, 3-21.  
 
 26
Meissner, H., Strebel, P., & Orenstein, W. (2004). Measles vaccines and the potential for 
worldwide eradication of measles. Pediatrics, 114(4), 1065-1069.  
 
Murphy, J. (2007). International perspectives and initiatives. Health Information and 
Libraries Journal, 24, 62-68.  
 
Newhouse, J. (1987). Cross national differences in health spending – what do they 
mean? Journal of Health Economics, 6, 159-162.  
 
Novarro, V., Borrell, C., Benach, J., Muntaner, C., Quiroga, A., Rodriguez-Sanz, M., et 
al. The importance of the political and the social in explaining mortality differentials 
among the countries of the OECD, 1950-1998. International Journal of Health Services, 
33(3), 419-494.  
 
Organisation for Economic Co-operation and Development (OECD) (2007). Retrieved 
March 29, 2007, from http://www.oecd.org 
 
Organisation for Economic Co-operation and Development OECD (2005). Health at a 
glance: OECD Indicators 2005. Paris, France: OECD. 
 
Oster, N., Harpaz, R., Redd, S., & Papania, M. (2004). International importation of 
measles virus- United States, 1993-2001. Journal of Infectious Diseases 189(Suppl. 1), 
48-53.  
 
Schieber, G. & Poullier, J. (1991). International health spending: Issues and trends. 
Health Affairs, 10(1) 106-116. 
 
Strebel, P., Cochi, S., Grabowsky, M., Bilous, J., Hersch, B., Okwo-Bele, J., et al. 
(2003). The unfinished measles immunization agenda.  Journal of Infectious Diseases, 
187(Suppl. 1), 1-7. 
 
Taylor, A. (2004). Governing the globalization of public health. The Journal of Law, 
Medicine, and Ethics, 32(3), 500-508, Fall 2004. 
 
Walker, B., Evans, C., & Mouton, C. (2006). Workshop on global health trends for 
health professional education. Journal of Health Care for the Poor and Underserved, 17, 
12-16.  
 
Waters, W. (2001). Globalization, socioeconomic restructuring, and community health. 
Journal of Community Health, 26(2), 79-92. 
 
Weisbrot, M., Baker, D., Kraev, E., & Chen, J. (2001). The scorecard on globalization 
1980-2000: Twenty years of dimished progress, CEPR Briefing Paper. Washington 
D.C.: Center for Economic and Policy Research.  
 27
 
World Health Organization [WHO]. (2002). Initiative for vaccine research. Retrieved 
May 30, 2007, from http://www.who.int/vaccine_research/diseases/measles/en/ 
 28
VITA 
 
 
Name:   Christina Melonie Chen 
Address: Texas A&M University, Department of Health and Kinesiology, 
MS 4243, College Station, TX 77840-4243 
Email Address: cmchen@alumni.rice.edu 
 
Education:   B.A., Asian Studies/Policy Studies, Rice University, 2006 
   M.S., Health Education, Texas A&M University, 2007  
